Suppr超能文献

弥漫性大 B 细胞淋巴瘤全基因组启动子甲基化。

Genome-wide promoter methylation of hairy cell leukemia.

机构信息

Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland.

SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.

出版信息

Blood Adv. 2019 Feb 12;3(3):384-396. doi: 10.1182/bloodadvances.2018024059.

Abstract

Classic hairy cell leukemia (HCL) is a tumor of mature clonal B cells with unique genetic, morphologic, and phenotypic features. DNA methylation profiling has provided a new tier of investigation to gain insight into the origin and behavior of B-cell malignancies; however, the methylation profile of HCL has not been specifically investigated. DNA methylation profiling was analyzed with the Infinium HumanMethylation27 array in 41 mature B-cell tumors, including 11 HCL, 7 splenic marginal zone lymphomas (SMZLs), and chronic lymphocytic leukemia with an unmutated (n = 7) or mutated (n = 6) immunoglobulin gene heavy chain variable (IGHV) region or using IGHV3-21 (n = 10). Methylation profiles of nontumor B-cell subsets and gene expression profiling data were obtained from public databases. HCL had a methylation signature distinct from each B-cell tumor entity, including the closest entity, SMZL. Comparison with normal B-cell subsets revealed the strongest similarity with postgerminal center (GC) B cells and a clear separation from pre-GC and GC cellular programs. Comparison of the integrated analysis with post-GC B cells revealed significant hypomethylation and overexpression of BCR-TLR-NF-κB and BRAF-MAPK signaling pathways and cell adhesion, as well as hypermethylation and underexpression of cell-differentiation markers and methylated genes in cancer, suggesting regulation of the transformed hairy cells through specific components of the B-cell receptor and the BRAF signaling pathways. Our data identify a specific methylation profile of HCL, which may help to distinguish it from other mature B-cell tumors.

摘要

经典型毛细胞白血病(HCL)是一种成熟克隆 B 细胞肿瘤,具有独特的遗传、形态和表型特征。DNA 甲基化谱分析为深入了解 B 细胞恶性肿瘤的起源和行为提供了一个新的研究层次;然而,HCL 的甲基化谱尚未得到专门研究。我们用 Infinium HumanMethylation27 阵列分析了 41 种成熟 B 细胞肿瘤,包括 11 例 HCL、7 例脾边缘区淋巴瘤(SMZL)、7 例未突变(n = 7)或突变(n = 6)免疫球蛋白基因重链可变区(IGHV)的慢性淋巴细胞白血病,或使用 IGHV3-21(n = 10)。从公共数据库获得了非肿瘤 B 细胞亚群的甲基化谱和基因表达谱数据。HCL 的甲基化特征与每种 B 细胞肿瘤实体均不同,包括最接近的实体 SMZL。与正常 B 细胞亚群的比较显示与生发中心后(GC)B 细胞的相似性最强,与 GC 前和 GC 细胞程序明显分离。与 GC 后 B 细胞的综合分析比较表明,BCR-TLR-NF-κB 和 BRAF-MAPK 信号通路以及细胞黏附的过度甲基化和过表达,以及细胞分化标记物和甲基化基因的低甲基化和低表达,表明通过 B 细胞受体和 BRAF 信号通路的特定成分调节转化的毛细胞。我们的数据确定了 HCL 的特定甲基化谱,这可能有助于将其与其他成熟 B 细胞肿瘤区分开来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7479/6373742/c07fe87b64d1/advances024059absf1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验